Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Cardiovascular system – other than umbilical artery or vein
Reexamination Certificate
2006-04-04
2006-04-04
Ketter, James (Department: 1636)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Cardiovascular system, other than umbilical artery or vein
C623S011110
Reexamination Certificate
active
07022348
ABSTRACT:
A method of creating an implantation material from biological and tissue engineered biosynthetic and biological tissue of autogenic, allogenic and xenogenic origin suitable for implantation into humans or animals as surgical and vascular prostheses. The resultant material inhibits in vivo calcification and provides a non-porous biomatrix which is impervious to angiogenesis and tissue ingrowth and suitable for the adhesion and retention of transplanted living cells such as endothelial cells, without the need for additional extracellular matrix protein coating. The method, which incorporates a gradual increase in glutaraldehyde concentration from 0% to no more than 5% weight/volume in a pH which is gradually changed from acid to alkaline at room temperature, maintains the micro-architecture and the cellular lining of the material. Additionally flexibility, compliance and haemo-compatibility along with strength and durability can be varied according to the end use. The glutaraldehyde penetrates the material gradually and completely, cross linking the collagenous components of the tissue.
REFERENCES:
patent: 3966401 (1976-06-01), Hancock et al.
patent: 4319363 (1982-03-01), Ketharanathan
patent: 4466139 (1984-08-01), Ketharanathan
patent: 4648881 (1987-03-01), Carpentier et al.
patent: 4681588 (1987-07-01), Ketharanathan
patent: 4798611 (1989-01-01), Freeman, Jr.
patent: 4820626 (1989-04-01), Williams et al.
patent: 5632778 (1997-05-01), Goldstein
patent: 5746775 (1998-05-01), Levy et al.
patent: 5843181 (1998-12-01), Jaffe et al.
patent: 5931969 (1999-08-01), Carpentier et al.
patent: WO 87/02880 (1987-05-01), None
patent: WO 96/28196 (1996-09-01), None
patent: WO 98/04299 (1998-02-01), None
Zilla et al., Biotechnol. Appl. Biochem., vol. 40, 2004, pp. 57-66.
Derwent Abstract Accession No. 42142C & JP 55034064 (Nitta Gelatin KK) Mar. 10, 1980. See the abstract.
Derwent Abstract Accession No. 76114C & JP 55118745 (Mitsubishi Rayon KK) Sep. 11, 1980. See the abstract.
Carpentier A., et al, (1971) Utilisation de biopolymeres dans la construction de protheses valvulaires cardiaques, C.R. Acad. Sc. Paris, vol. 272, No. 1, series D, 178-179.
Derwent Abstract for AU-004308 (Ketharanathan) (corresponding to AU-64816/80 and WO 82/00091; copy of WIPO document WO 82/00091 attached).
Vardaxis, N.J. et al. (1994) Chemical and physical properties of collagen implants influence their fate in vivo as evaluated by light and confocal microscopy, Journal of Biomedical Materials Research, vol. 28, 1013-1025.
Derwent Abstract for AU-001955 (Ketharanathan) (corresponding to AU-35532/84 and WO 85/01651; copy of WIPO document WO 85/01651 attached).
Burns, P. et al (1989) Performance of a New Vascular Xeno Prosthesis, ASAIO transactions, vol. 35, No. 3, 214-218.
Harriger, M.D. et al. (1997) Glutaraldehyde crosslinking of collagen substrates inhibits degradation in skin substitutes grafted to athymic mice, Journal of Biomedical Materials Research, vol. 35, No. 2, 137-145.
Ketter James
Stevens & Showalter LLP
LandOfFree
Method of creating biological and biosynthetic material for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of creating biological and biosynthetic material for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of creating biological and biosynthetic material for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3613642